ArticleAnnals of surgical treatment and research2026
Dacron vascular grafts: a long-term solution for short renal vein challenges in living donor kidney transplantation in a retrospective case series.
Article in Annals of surgical treatment and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bridging the gap: overcoming anatomical challenges in kidney transplantation with prosthetic grafts.Annals of surgical treatment and research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Short renal veins in living donor kidney transplantation present technical challenges during graft placement and vascular anastomosis. Artificial graft use raises concerns about infection and thrombosis. We share our experiences using Dacron vascular grafts (Hemagard, Maquet) for renal vein extension with long-term safety and efficacy. Methods: We retrospectively reviewed 11 cases at Seoul National University Hospital (2016-2024) where Dacron vascular grafts were used for renal vein extension. Patient demographics, comorbidities, graft size, and postoperative antiplatelet therapy were analyzed. Imaging follow-up was performed with sonography before discharge. Results: Patients had a median age of 56 years and a median body mass index of 25.0 kg/m Conclusion: Dacron vascular grafts for renal vein extension in living donor kidney transplantation are a reliable and effective surgical option, demonstrating favorable long-term safety and patency without increased thrombotic or infectious complications under antiplatelet management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.